Literature DB >> 16177324

Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity.

Daniel N Wolfe1, Girish S Kirimanjeswara, Eric T Harvill.   

Abstract

Bordetella parapertussis and Bordetella pertussis are closely related species that cause whooping cough, an acute, immunizing disease. Their coexistence in the same host populations at the same time and vaccine studies showing that B. pertussis vaccines have little effect on B. parapertussis infection or disease suggest that the protective immunity induced by each does not efficiently cross protect against the other. Although the mechanisms of protective immunity to B. pertussis have been well studied, those of B. parapertussis have not. The present study explores the mechanism by which B. parapertussis is cleared from the lower respiratory tract by anamnestic immunity. Serum antibodies are necessary and sufficient for elimination of this bacterium, and CD4(+) T cells, complement, and neutrophils are required for serum antibody-mediated clearance. Mice lacking immunoglobulin A had no defect in their ability to control or clear infection. Interestingly, serum antibody-mediated clearance of B. parapertussis did not require Fc receptors that are required for antibody-mediated clearance of B. pertussis. Together these data support a model for the mechanism of protective immunity to B. parapertussis that is similar but distinct from that of B. pertussis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177324      PMCID: PMC1230969          DOI: 10.1128/IAI.73.10.6508-6513.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis.

Authors:  Girish S Kirimanjeswara; Luis M Agosto; Mary J Kennett; Ottar N Bjornstad; Eric T Harvill
Journal:  J Clin Invest       Date:  2005-11-17       Impact factor: 14.808

2.  Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.

Authors:  M Watanabe; M Nagai
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

3.  Epidemiology of pertussis in a West African community before and after introduction of a widespread vaccination program.

Authors:  Marie-Pierre Préziosi; Abdoulaye Yam; Steven G F Wassilak; Laurence Chabirand; Aminata Simaga; Malick Ndiaye; Marème Dia; François Dabis; François Simondon
Journal:  Am J Epidemiol       Date:  2002-05-15       Impact factor: 4.897

4.  Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide O side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia.

Authors:  Guadalupe Cortés; Nuria Borrell; Beatriz de Astorza; Cristina Gómez; Jaume Sauleda; Sebastián Albertí
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

5.  Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection.

Authors:  E T Harvill; A Preston; P A Cotter; A G Allen; D J Maskell; J F Miller
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

6.  Role of Bordetella O antigen in respiratory tract infection.

Authors:  Valorie C Burns; Elizabeth J Pishko; Andrew Preston; Duncan J Maskell; Eric T Harvill
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

7.  Role of systemic and mucosal immune responses in reciprocal protection against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.

Authors:  Mineo Watanabe; Masaaki Nagai
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

8.  Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells.

Authors:  Mangala Rao; Mike Bray; Carl R Alving; Peter Jahrling; Gary R Matyas
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Comparative phenotypic analysis of the Bordetella parapertussis isolate chosen for genomic sequencing.

Authors:  Ulrich Heininger; Peggy A Cotter; Howard W Fescemyer; Guillermo Martinez de Tejada; Ming H Yuk; Jeff F Miller; Eric T Harvill
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

10.  Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?

Authors:  F R Mooi; I H van Loo; A J King
Journal:  Emerg Infect Dis       Date:  2001       Impact factor: 6.883

View more
  20 in total

1.  Use of a genetically defined double mutant strain of Bordetella bronchiseptica lacking adenylate cyclase and type III secretion as a live vaccine.

Authors:  Paul Mann; Elizabeth Goebel; James Barbarich; Mylisa Pilione; Mary Kennett; Eric Harvill
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

2.  Replacement of adenylate cyclase toxin in a lineage of Bordetella bronchiseptica.

Authors:  Anne M Buboltz; Tracy L Nicholson; Mylisa R Parette; Sara E Hester; Julian Parkhill; Eric T Harvill
Journal:  J Bacteriol       Date:  2008-06-13       Impact factor: 3.490

3.  Functional Immune Cell Differences Associated With Low Vaccine Responses in Infants.

Authors:  Michael E Pichichero; Janet R Casey; Anthony Almudevar; Saleem Basha; Naveen Surendran; Ravinder Kaur; Matthew Morris; Alexandra M Livingstone; Tim R Mosmann
Journal:  J Infect Dis       Date:  2016-02-09       Impact factor: 5.226

4.  Bordetella parapertussis survives the innate interaction with human neutrophils by impairing bactericidal trafficking inside the cell through a lipid raft-dependent mechanism mediated by the lipopolysaccharide O antigen.

Authors:  Juan Gorgojo; Yanina Lamberti; Hugo Valdez; Eric T Harvill; Maria Eugenia Rodríguez
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

5.  Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis.

Authors:  Gráinne H Long; Alexia T Karanikas; Eric T Harvill; Andrew F Read; Peter J Hudson
Journal:  Proc Biol Sci       Date:  2010-03-03       Impact factor: 5.349

6.  O antigen protects Bordetella parapertussis from complement.

Authors:  Elizabeth M Goebel; Daniel N Wolfe; Kelly Elder; Scott Stibitz; Eric T Harvill
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

7.  O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies.

Authors:  Xuqing Zhang; Maria Eugenia Rodríguez; Eric T Harvill
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

8.  Comparative role of immunoglobulin A in protective immunity against the Bordetellae.

Authors:  Daniel N Wolfe; Girish S Kirimanjeswara; Elizabeth M Goebel; Eric T Harvill
Journal:  Infect Immun       Date:  2007-06-25       Impact factor: 3.441

9.  The O antigen is a critical antigen for the development of a protective immune response to Bordetella parapertussis.

Authors:  Xuqing Zhang; Elizabeth M Goebel; Maria Eugenia Rodríguez; Andrew Preston; Eric T Harvill
Journal:  Infect Immun       Date:  2009-09-08       Impact factor: 3.441

10.  Bordetella pertussis infection or vaccination substantially protects mice against B. bronchiseptica infection.

Authors:  Elizabeth M Goebel; Xuqing Zhang; Eric T Harvill
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.